Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,030 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
Salem R, Lewandowski RJ, Kulik L, Wang E, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Ibrahim SM, Senthilnathan S, Baker T, Gates VL, Atassi B, Newman S, Memon K, Chen R, Vogelzang RL, Nemcek AA, Resnick SA, Chrisman HB, Carr J, Omary RA, Abecassis M, Benson AB 3rd, Mulcahy MF. Salem R, et al. Gastroenterology. 2011 Feb;140(2):497-507.e2. doi: 10.1053/j.gastro.2010.10.049. Epub 2010 Oct 30. Gastroenterology. 2011. PMID: 21044630 Free PMC article.
Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.
Memon K, Kulik L, Lewandowski RJ, Wang E, Riaz A, Ryu RK, Sato KT, Marshall K, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Senthilnathan S, Baker T, Gates VL, Abecassis M, Benson AB 3rd, Mulcahy MF, Omary RA, Salem R. Memon K, et al. Among authors: salem r. Gastroenterology. 2011 Aug;141(2):526-35, 535.e1-2. doi: 10.1053/j.gastro.2011.04.054. Epub 2011 Apr 30. Gastroenterology. 2011. PMID: 21664356 Free PMC article.
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis.
Memon K, Kulik L, Lewandowski RJ, Wang E, Ryu RK, Riaz A, Nikolaidis P, Miller FH, Yaghmai V, Baker T, Abecassis M, Benson AB 3rd, Mulcahy MF, Omary RA, Salem R. Memon K, et al. Among authors: salem r. J Hepatol. 2012 May;56(5):1112-1120. doi: 10.1016/j.jhep.2011.11.020. Epub 2012 Jan 13. J Hepatol. 2012. PMID: 22245905 Free PMC article.
Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials.
Memon K, Kulik L, Lewandowski RJ, Gupta R, Ryu RK, Miller FH, Vouche M, Atassi R, Ganger D, Mulcahy MF, Salem R. Memon K, et al. Among authors: salem r. J Vasc Interv Radiol. 2013 Aug;24(8):1189-1197.e2. doi: 10.1016/j.jvir.2012.12.025. Epub 2013 Mar 7. J Vasc Interv Radiol. 2013. PMID: 23474327
Locoregional therapy of hepatocellular carcinoma.
Habib A, Desai K, Hickey R, Thornburg B, Lewandowski R, Salem R. Habib A, et al. Among authors: salem r. Clin Liver Dis. 2015 May;19(2):401-20. doi: 10.1016/j.cld.2015.01.008. Epub 2015 Mar 12. Clin Liver Dis. 2015. PMID: 25921670 Review.
Radioembolization for hepatocellular carcinoma: Statistical confirmation of improved survival in responders by landmark analyses.
Riaz A, Gabr A, Abouchaleh N, Ali R, Al Asadi A, Mora R, Kulik L, Desai K, Thornburg B, Mouli S, Hickey R, Miller FH, Yaghmai V, Ganger D, Lewandowski RJ, Salem R. Riaz A, et al. Among authors: salem r. Hepatology. 2018 Mar;67(3):873-883. doi: 10.1002/hep.29480. Epub 2018 Jan 26. Hepatology. 2018. PMID: 28833344 Clinical Trial.
1,030 results